BK
72
4
EXR
60
3
SO
57
2
BA
49
-3
WM
76
3
GILD
49
2
WEC
55
2
EXPE
91
3
NTAP
66
2
MOS
46
4
F
47
4
XRX
41
6
PSA
56
5
AIV
70
2
FMC
33
2
CAH
53
6
NWS
69
7
CVX
44
-2
GLW
46
4
FITB
60
2
BK
72
4
EXR
60
3
SO
57
2
BA
49
-3
WM
76
3
GILD
49
2
WEC
55
2
EXPE
91
3
NTAP
66
2
MOS
46
4
F
47
4
XRX
41
6
PSA
56
5
AIV
70
2
FMC
33
2
CAH
53
6
NWS
69
7
CVX
44
-2
GLW
46
4
FITB
60
2
Financhill
Back

Cemex SAB de CV 10K Form

Buy
69

CX
Cemex SAB de CV

Last Price:
5.52
Seasonality Move:
9.67%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CX News And Ratings

See the #1 stock for the next 7 days that we like better than CX

CX Financial Statistics

Sales & Book Value

Annual Sales: $17.39B
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $8.34
Price / Book: 0.65

Profitability

EPS (TTM): 0.29740
Net Income (TTM): $449.34M
Gross Margin: $5.86B
Return on Equity: 3.67%
Return on Assets: 1.6%

Cemex SAB de CV Earnings Forecast

Key Cemex SAB de CV Financial Ratios

  • The Gross Profit Margin over the past 28 years for CX is 33.71%.
  • The Selling, General & Administrative Expenses for CX have been equal to 7.99% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is 315.93% of Operating Income.
  • The Net Earning history of CX is 1.05% of Total Revenues.
  • Per Share Earnings over the last 28 years have been positive in 13 years.

Cemex SAB de CV Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Construction Materials
Sector: Materials
Current Symbol: CX
CUSIP: 151290
Website: cemex.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0.98
Quick Ratio: 0.5

Price-to-Earnings

Trailing P/E Ratio: 44.31
Forward P/E Ratio: 6.89

CX Technical Analysis vs Fundamental Analysis

Buy
69
Cemex SAB de CV (CX) is a Buy

Is Cemex SAB de CV a Buy or a Sell?

  • Cemex SAB de CV stock is rated a Buy
    The current Cemex SAB de CV [CX] share price is $5.45. The Score for CX is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.